Physician profile
Kunal Bhan
NPI 1902420813
$7,000.34
in general payments reported to CMS, 2019-2025
23 companies · $2,176 in 2025
The $2,176 reported for 2025 was more than what 85% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $152 · 2021: $1,214 · 2022: $287 · 2023: $2,671 · 2024: $502 · 2025: $2,176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,877 · Food and Beverage: $2,471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,876.50 |
| Food and Beverage | $2,471.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $2,091.11 | 2023-2025 | Truelok, Physio-Stim |
| Treace Medical Concepts, INC. | $1,645.23 | 2023-2025 | |
| Pinnacle, INC | $1,214.08 | 2021 | |
| Depuy Synthes Sales INC. | $545.92 | 2023-2025 | Motoband, Na, Fibergraft Aeridyan Matrix |
| Biotissue Holdings INC. | $208.30 | 2025 | |
| Integra Lifesciences Corporation | $176.41 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Inari Medical, INC. | $154.08 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Paragon 28, INC. | $142.72 | 2020-2025 | Phantom Fibula Nail, Monkey Rings |
| Smith+Nephew, INC. | $134.32 | 2020-2024 | Renasys Go V2 Home |
| Abbvie INC. | $117.33 | 2022 | |
| Medtronic, INC. | $94.43 | 2023 | Venaseal |
| Kerecis Limited | $91.69 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Medical Device Business Services, INC. | $77.05 | 2024 | Fibulink |
| Stryker Corporation | $71.67 | 2025 | Valor, Hoffmann, Prostep |
| Biocomposites INC | $50.57 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $43.17 | 2022 | |
| Ibsa Pharma INC. | $24.28 | 2024 | Tirosint, Licart |
| Averitas Pharma INC. | $23.42 | 2023 | Qutenza |
| Kci USA, INC. | $23.26 | 2023 | Activ.A.C., V.A.C. Dermatac |
| Tactile Systems Technology INC | $22.57 | 2024 | Entre Plus, Flexitouch Plus |
| Bioventus LLC | $18.70 | 2024 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $16.46 | 2024 | Nuzyra |
| Boston Scientific Corporation | $13.57 | 2024 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunal Bhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.